Applied Clinical Trials
The developed markets of North America and Europe together saw approximately 81% of the Phase I trial share in 2013 which is a 6% increase from 2012. Trials
Dr. J. Fred Pritchard, PhD
Advertisement
Dr. Pritchard ?is the Vice President, Global Drug Development, with Celerion, Raleigh-Durham, North Carolina.
Articles by Dr. J. Fred Pritchard, PhD
Advertisement
Latest Updated Articles
Is South Korea the Next Emerging Early Phase Destination?January 29th 2015
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
3
ACT Brief: Enterprise Risk Management, Execution Architecture for AI, and Rare Pediatric Regulatory Support
4
AI-Driven Clinical Trial Recruitment and Design
5